Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study

Research output: Contribution to journalLetterpeer-review

Abstract / Description of output

This multicentre study showed that COVID-19 vaccination appears to be safe and effective in patients with fatty liver.
Original languageEnglish
JournalJournal of Hepatology
Early online date24 Apr 2021
DOIs
Publication statusE-pub ahead of print - 24 Apr 2021

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study'. Together they form a unique fingerprint.

Cite this